Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-22 19:38 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Croatia · Hungary · Japan · Poland · Portugal · Slovakia · South Korea · Spain · Thailand · United States
Registry dates and results
Start: 2026-04-17. Completion: 2027-10-01 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
NNC0662-0419 (drug)
Semaglutide (drug)
Placebo (drug)
Where the study takes place — 63 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Lancaster, California, United States
Explore the world’s study registries
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Start: 2026-10-12. Completion: 2028-03-24 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
zovaglutide Arm 1 (drug) — also listed as: ZT002 Injection
zovaglutide Arm 2 (drug) — also listed as: ZT002 Injection
semaglutide (drug)
Where the study takes place — 16 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Peking University People's Hospital Beijing, Beijing Municipality, China Site recruitment: Not reported
Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China Site recruitment: Not reported
Huizhou Central People's Hospital Huizhou, Guangdong, China Site recruitment: Not reported
Handan First Hospital Handan, Hebei, China Site recruitment: Not reported
Hebei Petro China Cental Hospital Langfang, Hebei, China Site recruitment: Not reported
Harbin Medical University Affiliated Fourth Hospital Harbin, Heilongjiang, China Site recruitment: Not reported
The First Affiliated of Nanyang Medical College Nanyang, Henan, China Site recruitment: Not reported
Yichang Central People's Hospital (Xiling Campus) Yichang, Hubei, China Site recruitment: Not reported
The First People's Hospital of Changde Changde, Hunan, China Site recruitment: Not reported
Jilin Province FAW General Hospital Changchun, Jilin, China Site recruitment: Not reported
The Fifth People's Hospital of Shenyang Shenyang, Liaoning, China Site recruitment: Not reported
Central Hospital Affiliated to Shandong First Medical University Jinan, Shandong, China Site recruitment: Not reported
Zibo Central Hospital Zibo, Shandong, China Site recruitment: Not reported
Zibo Municipal Hospital Zibo, Shandong, China Site recruitment: Not reported
Jincheng General Hospital Jincheng, Shanxi, China Site recruitment: Not reported
The 2nd People's Hospital of Chengdu Chengdu, Sichuan, China Site recruitment: Not reported
Start: 2025-09-26. Completion: 2028-02-09 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
CagriSema (Cagrilintide B + semaglutide I) (drug)
Low Energy Diet (behavioral)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Advent Health-Res Inst Orlando, Florida, United States Site recruitment: Not reported
Pennington Biomed Res Ctr Baton Rouge, Louisiana, United States Site recruitment: Not reported
Alcohol Use Disorder; Weight Loss; Bariatric Surgery Patients
Sponsor
Yale University
Countries with listed sites
United States
Registry dates and results
Start: 2026-03-26. Completion: 2027-02 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Semaglutide 1.0 mg (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Yale School of Medicine New Haven, Connecticut, United States Site recruitment: Not reported
Start: 2025-08-07. Completion: 2027-07 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Semaglutide (drug) — also listed as: Wegovy, Ozempic
Placebo (drug)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Institute of Human Virology at the University of Maryland School of Medicine Washington D.C., District of Columbia, United States Site recruitment: Not reported
Institute of Human Virology at the University of Maryland School of Medicine Baltimore, Maryland, United States Site recruitment: Not reported
Start: 2026-02-13. Completion: 2027-05-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Digi-physical treatment tool, Evira (device)
Obesity medication with liraglutide or semaglutide (drug)
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
HKH Crown Princess Victoria's Childrens and youth Hospital Linköping Linköping, Sweden Site recruitment: Recruiting
Länsverksamhet Barn- och ungdomsmedicin Sollefteå Sollefteå, Sweden Site recruitment: Recruiting
Ystad lasarett, Barn och ungdomsmedicinmottagningen Ystad, Sweden Site recruitment: Recruiting
Diabetes Mellitus, Type 2; Diabetic Peripheral Neuropathy
Sponsor
Novo Nordisk A/S
Countries with listed sites
Canada · Denmark · France · Norway · Spain · United Kingdom · United States
Registry dates and results
Start: 2025-01-29. Completion: 2026-08-05 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
CagriSema (Cagrilintide B and Semaglutide I) (drug)
Placebo matched to CagriSema (Cagrilintide B and Semaglutide I) (drug)
Where the study takes place — 55 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
eStudySite La Mesa, California, United States Site recruitment: Not reported
Linda Vista Health Care Ctr San Diego, California, United States Site recruitment: Not reported
My Preferred Research Miami, Florida, United States Site recruitment: Not reported
New Horizon Research Center Miami, Florida, United States Site recruitment: Not reported
Renstar Medical Research Ocala, Florida, United States Site recruitment: Not reported
Renstar Medical Research Ocala, Florida, United States Site recruitment: Not reported
Foot & Ankle Center of Illinois Springfield, Illinois, United States Site recruitment: Not reported
Velocity Clinical Research Rockville Rockville, Maryland, United States Site recruitment: Not reported
Amicis Centers of Clinical Research St Louis, Missouri, United States Site recruitment: Not reported
DM Clinical Albuquerque, New Mexico, United States Site recruitment: Not reported
Southgate Medical Group, LLP West Seneca, New York, United States Site recruitment: Not reported
Piedmont Healthcare/Research Statesville, North Carolina, United States Site recruitment: Not reported
Lillestol Research LLC Fargo, North Dakota, United States Site recruitment: Not reported
Oregon Health & Science University Portland, Oregon, United States Site recruitment: Not reported
Clinical Res Collaborative Cumberland, Rhode Island, United States Site recruitment: Not reported
DM Clinical Houston, Texas, United States Site recruitment: Not reported
Radiance Clinical Research Lampasas, Texas, United States Site recruitment: Not reported
DM Clinical Research San Antonio, Texas, United States Site recruitment: Not reported
DM Clinical San Antonio, Texas, United States Site recruitment: Not reported
Velocity Clinical Research Portsmouth Suffolk, Virginia, United States Site recruitment: Not reported
G.A. Research Associates Ltd. Moncton, New Brunswick, Canada Site recruitment: Not reported
Centricity Research Brampton Endocrinology Brampton, Ontario, Canada Site recruitment: Not reported
Centricity Clinical Research Burlington Burlington, Ontario, Canada Site recruitment: Not reported
Centricity Research Etobicoke Endocrinology Etobicoke, Ontario, Canada Site recruitment: Not reported
Premier Clinical Trial Research Network (PCTRN) Hamilton, Ontario, Canada Site recruitment: Not reported
Diabetes Heart Research Centre Toronto, Ontario, Canada Site recruitment: Not reported
Ctr de Med Metab de Lanaudiere Terrebonne, Quebec, Canada Site recruitment: Not reported
Aarhus Universitetshospital, Steno Diabetes Center Aarhus Aarhus N, Denmark Site recruitment: Not reported
Steno Diabetes Center Nordjylland Gistrup, Denmark Site recruitment: Not reported
Steno Diabetes Center Copenhagen Herlev, Denmark Site recruitment: Not reported
Kolding Sygehus Karkirurgi Kolding, Denmark Site recruitment: Not reported
Steno Diabetes Center Odense Odense C, Denmark Site recruitment: Not reported
Les Hopitaux de Chartres-Hopital Louis Pasteur Le Coudray, France Site recruitment: Not reported
Groupe Sos Sante-Hopital Le Creusot-Hotel Dieu Le Creusot, France Site recruitment: Not reported
Aphp-Hopital La Pitie Salpetriere Paris, France Site recruitment: Not reported
Centre Hospitalier Universitaire de Bordeaux-Hopital Haut Leveque Pessac, France Site recruitment: Not reported
Centre de Recherche Clinique Portes Du Sud Vénissieux, France Site recruitment: Not reported
Haukeland Universitetssykehus Bergen, Norway Site recruitment: Not reported
Sykehuset Innlandet HF Hamar Hamar, Norway Site recruitment: Not reported
Oslo universitetssykehus, Ullevål Oslo, Norway Site recruitment: Not reported
Stavanger Universitetssykehus, Helse Stavanger HF Stavanger, Norway Site recruitment: Not reported
Hospital Nisa Sevilla Aljarafe (To be inactivated when NN9388-7864 is in closing status) Castilleja de la Cuesta, Andalusia, Spain Site recruitment: Not reported
Hospital Germans Trias i Pujol Badalona, Barcelona, Spain Site recruitment: Not reported
Complejo Hospitalario Universitario A Coruña A Coruña, Spain Site recruitment: Not reported
Hospital Vall d'Hebron Barcelona, Spain Site recruitment: Not reported
Hospital Universitario de la Princesa Madrid, Spain Site recruitment: Not reported
Hospital Universitario Marqués de Valdecilla Santander, Spain Site recruitment: Not reported
H. Infanta Luisa_Endocrino y Obesidad Seville, Spain Site recruitment: Not reported
Tameside General Hospital Ashton-under-Lyne, Greater Manchester, United Kingdom Site recruitment: Not reported
Ipswich Hospital - Diabetes Ipswich, United Kingdom Site recruitment: Not reported
Aintree University Hospital Liverpool, United Kingdom Site recruitment: Not reported
St Pancras Clinical Research London, United Kingdom Site recruitment: Not reported
King's College Hospital - Renal London, United Kingdom Site recruitment: Not reported
Manchester Royal Infirmary - Diabetes Manchester, United Kingdom Site recruitment: Not reported
Royal Hallamshire Hospital Sheffield, United Kingdom Site recruitment: Not reported
Start: 2025-06-12. Completion: 2028-05-03 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Cagrilintide (drug)
Semaglutide (drug)
Placebo cagrilintide (drug)
Placebo semaglutide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Steno Diabetes Center Copenhagen Herlev, Denmark Site recruitment: Recruiting
China · Japan · Serbia · Slovakia · South Africa · United States
Registry dates and results
Start: 2024-03-26. Completion: 2025-10-23 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Cagrilintide (drug)
Semaglutide (drug)
Placebo (drug)
Where the study takes place — 61 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Valley Research Fresno, California, United States Site recruitment: Not reported
Valley Clinical Trials, Inc. Northridge, California, United States Site recruitment: Not reported
Bioclinical Research Alliance Miami, Florida, United States Site recruitment: Not reported
Solaris Clinical Research Meridian, Idaho, United States Site recruitment: Not reported
Iowa Diab & Endo Res Center West Des Moines, Iowa, United States Site recruitment: Not reported
Alliance for Multispec Res Newton, Kansas, United States Site recruitment: Not reported
Endo and Metab Consultants Rockville, Maryland, United States Site recruitment: Not reported
Elite Research Center Flint, Michigan, United States Site recruitment: Not reported
Palm Research Center Inc. Las Vegas, Nevada, United States Site recruitment: Not reported
University of North Carolina Chapel Hill, North Carolina, United States Site recruitment: Not reported
Holston Medical Group Kingsport, Tennessee, United States Site recruitment: Not reported
Clinical Research Associates Nashville, Tennessee, United States Site recruitment: Not reported
Velocity Clinical Res-Dallas Dallas, Texas, United States Site recruitment: Not reported
Synergy Groups Medical Houston, Texas, United States Site recruitment: Not reported
PlanIt Research, PLLC Houston, Texas, United States Site recruitment: Not reported
Simcare Medical Research, LLC Sugar Land, Texas, United States Site recruitment: Not reported
Manassas Clinical Research Center Manassas, Virginia, United States Site recruitment: Not reported
TPMG Clinical Research Newport News, Virginia, United States Site recruitment: Not reported
Chinese People's Liberation Army General Hospital-Endocrinology Beijing, Beijing Municipality, China Site recruitment: Not reported
Huaihe Hospital of Henan University-Endocrinology Kaifeng, Henan, China Site recruitment: Not reported
Huaihe Hospital of Henan University Kaifeng, Henan, China Site recruitment: Not reported
The Second Affiliated Hospital of Nanjing Medical University-Endocrinology Nanjing, Jiangsu, China Site recruitment: Not reported
The Second Affiliated Hospital of Nanjing Medical University_Nanjing Nanjing, Jiangsu, China Site recruitment: Not reported
The Affiliated Hospital of Jiangsu University-Endocrinology Zhenjiang, Jiangsu, China Site recruitment: Not reported
Jinan Central Hospital Ji'nan, Shandong, China Site recruitment: Not reported
Jinan Central Hospital Jinan, Shandong, China Site recruitment: Not reported
Shanghai Pudong New Area People's Hospital-Endocrinology Shanghai, Shanghai Municipality, China Site recruitment: Not reported
Manda Memorial Hospital_Internal Medicine Sapporo-shi, Hokkaido, Hokkaido, Japan, Japan Site recruitment: Not reported
Tsuruma Kaneshiro Diabetes Clinic_Internal medicine Yamato-shi, Kanagawa, Japan Site recruitment: Not reported
Kumanomae Nishimura Naika Clinic_Internal Medicine Arakawa-ku, Tokyo, Japan Site recruitment: Not reported
Akaicho Clinic Chiba-shi, Chiba, Japan Site recruitment: Not reported
Futata Tetsuhiro Clinic Meinohama_Internal medicine Fukuoka-shi, Fukuoka, Japan Site recruitment: Not reported
Kunisaki Makoto Clinic Fukuoka-shi, Fukuoka, Japan Site recruitment: Not reported
Sasaki Internal Medicine Hokkaido, Japan Site recruitment: Not reported
Naka Kinen Clinic_Internal medicine Ibaraki, Japan Site recruitment: Not reported
H.E.C Science Clinic_Internal Medicine, Diabetes Kanagawa, Japan Site recruitment: Not reported
H.E.C Science Clinic Kanagawa, Japan Site recruitment: Not reported
Kyoto University Hospital_Department of Diabetes, Endocr Kyoto-shi, Kyoto, Japan Site recruitment: Not reported
Minami Akatsuka Clinic_internal medicine Mito-shi, Ibaraki, Japan Site recruitment: Not reported
Tokyo-Eki Center-building Clinic_Internal Medicine Tokyo, Japan Site recruitment: Not reported
Tokyo-Eki Center-building Clinic Tokyo, Japan Site recruitment: Not reported
Fukuwa Clinic_Internal Medicine Tokyo, Japan Site recruitment: Not reported
Kato Clinic of Internal Medicine_Internal Medicine Tokyo, Japan Site recruitment: Not reported
Healthcare centre Zvezdara Belgrade, RS, Serbia Site recruitment: Not reported
Healthcare centre Kragujevac Kragujevac, RS, Serbia Site recruitment: Not reported
University Clinical Centre Nis Niš, RS, Serbia Site recruitment: Not reported
Healthcare centre Nis Niš, RS, Serbia Site recruitment: Not reported
Policlinic for diabetes Zaječar, Serbia Site recruitment: Not reported
MOMED, s.r.o Kráľovský Chlmec, Slovakia Site recruitment: Not reported
DIA - KONTROL s.r.o. Levice, Slovakia Site recruitment: Not reported
SIN AZUCAR s.r.o. Malacky, Slovakia Site recruitment: Not reported
ENRIN, s.r.o. Rimavská Sobota, Slovakia Site recruitment: Not reported
LUDIA, s. r. o. Spišská Nová Ves, Slovakia Site recruitment: Not reported
Oraderumaz (Pty) Ltd Bloemfontein, Free State, South Africa Site recruitment: Not reported
Hemant Makan Johannesburg, Gauteng, South Africa Site recruitment: Not reported
Lenasia Clinical Trial Centre Lenasia, Gauteng, South Africa Site recruitment: Not reported
Prinshof Medical Campus Pretoria, Gauteng, South Africa Site recruitment: Not reported
Clinical Trial Systems (CTC) Pretoria, Gauteng, South Africa Site recruitment: Not reported
Dr Vawda's site Durban, KwaZulu-Natal, South Africa Site recruitment: Not reported
Ashmed Medi-Centre Cape Town, Western Cape, South Africa Site recruitment: Not reported
Dr Noeth's Practice Pretoria, South Africa Site recruitment: Not reported
Belgium · Bulgaria · Denmark · France · Greece · Netherlands · Poland · Spain · Sweden · United States
Registry dates and results
Start: 2026-08-12. Completion: 2028-04-11 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Semaglutide (drug)
Placebo (drug)
Where the study takes place — 62 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Uni of Alabama at Birmingham Birmingham, Alabama, United States Site recruitment: Recruiting
Headlands Research California, LLC Escondido, California, United States Site recruitment: Recruiting
National Research Institute - Huntington Park Huntington Park, California, United States Site recruitment: Recruiting
Los Angeles Institute for Metabolic Research Los Angeles, California, United States Site recruitment: Recruiting
ERG Holding Company, LLC / Evolution Research Group, LLC Delray Beach, Florida, United States Site recruitment: Recruiting
ERG Holding Company, LLC / Evolution Research Group, LLC Fort Myers, Florida, United States Site recruitment: Recruiting
Jedidiah Clinical Research Tampa, Florida, United States Site recruitment: Recruiting
East West Med Res Inst Honolulu, Hawaii, United States Site recruitment: Recruiting
L-MARC Research Center Louisville, Kentucky, United States Site recruitment: Recruiting
StudyMetrix Research LLC City of Saint Peters, Missouri, United States Site recruitment: Recruiting
Jubilee Clinical Research, Inc. Las Vegas, Nevada, United States Site recruitment: Recruiting
Corvallis Clinic PC Clinical Research Department Corvallis, Oregon, United States Site recruitment: Recruiting
UPA Ctr Weight and Eating Dis Philadelphia, Pennsylvania, United States Site recruitment: Not yet recruiting
Spartanburg Medical Research Spartanburg, South Carolina, United States Site recruitment: Recruiting
Cedar Health Research Dallas, Texas, United States Site recruitment: Recruiting
Selma Medical Associates Winchester, Virginia, United States Site recruitment: Recruiting
Anima Research Center Alken, Belgium Site recruitment: Recruiting
Imelda Bonheiden, Belgium Site recruitment: Recruiting
UZ Brussel - Universitair Ziekenhuis Brussel Brussels, Belgium Site recruitment: Recruiting
Universitair Ziekenhuis Gent Ghent, Belgium Site recruitment: Recruiting
KORMONT Kluisbergen, Belgium Site recruitment: Recruiting
AIPSMC - DiMed EOOD Haskovo, Bulgaria Site recruitment: Recruiting
Medical Center Zdrave Lom EOOD Lom, Bulgaria Site recruitment: Recruiting
IPMC - Dr. Elizabeta Dimitrova Petrich, Bulgaria Site recruitment: Not yet recruiting
MHAT Hadzhi Dimitar OOD Sliven, Bulgaria Site recruitment: Recruiting
DCC Neoklinik EAD Sofia, Bulgaria Site recruitment: Recruiting
DCC 1 Velingrad EOOD Velingrad, Bulgaria Site recruitment: Recruiting
Aarhus Universitetshospital, Steno Diabetes Center Aarhus Aarhus N, Denmark Site recruitment: Recruiting
Gentofte Hospital - Center for Klinisk Metabolisk Forskning Hellerup, Denmark Site recruitment: Recruiting
Regionshospitalet Gødstrup, Hjertesygdomme Herning, Denmark Site recruitment: Recruiting
Hôpital Privé Saint Martin_Service de chirurgie digestive Caen, France Site recruitment: Recruiting
LES HOPITAUX DE CHARTRES_HOPITAL LOUIS PASTEUR_Service d'endocrinologie Le Coudray, France Site recruitment: Recruiting
Hôpital Privé La Louvière_Service de chirurgie Lille, France Site recruitment: Recruiting
CENTRE DE RECHERCHE CLINIQUE PORTES DU SUD_Service d'Endocrinologie-Diabétologie-Maladies Métaboliques Vénissieux, France Site recruitment: Recruiting
City Hospital Kliniki Monoprosopi I.K.E. Kalamata, Greece Site recruitment: Recruiting
Athens Medical Center S.A. (Iatriko Athinon) - Diabetes and Obesity Unit Marousi, Greece Site recruitment: Recruiting
Athens Medical Center S.A. (Iatriko Peristeriou) - Diabetes, obesity and cardiometabolic diseases department Peristeri, Greece Site recruitment: Recruiting
NextHealth S.A. - Department of Endocrinology, Metabolism & Diabetes Thessaloniki, Greece Site recruitment: Recruiting
Thermi Clinic S.A. - Diabetes and Internal Medicine Department Thessaloniki, Greece Site recruitment: Recruiting
Progress Clinical Research Amsterdam Amsterdam, Netherlands Site recruitment: Recruiting
Praktijk Dokters van Nederhoven Zwijndrecht, Netherlands Site recruitment: Recruiting
Progress Clinical Research Zwolle Zwolle, Netherlands Site recruitment: Recruiting
Kresmed Sp. z o. o. Bialystok, Poland Site recruitment: Not yet recruiting
Athleticomed Sp. z o.o. Bydgoszcz, Poland Site recruitment: Not yet recruiting
Gierach-Med Bygdoszcz, Poland Site recruitment: Recruiting
Santa Sp. z o.o. Lodz, Poland Site recruitment: Not yet recruiting
Centrum Zdrowia Metabolicznego Paweł Bogdański Poznan, Poland Site recruitment: Recruiting
Velocity Nova Sp. z o.o. Staszów, Poland Site recruitment: Recruiting
NBR Polska Tomasz Klodawski Warsaw, Poland Site recruitment: Recruiting
Care Access Polska Sp. Z o.o. Warsaw, Poland Site recruitment: Not yet recruiting
FutureMeds Sp. z o.o. Warsaw, Poland Site recruitment: Recruiting
HU de Fuenlabrada_Endocrinología Fuenlabrada, Madrid, Spain Site recruitment: Not yet recruiting
CPE Bola Azul_Endocrinología y Nutrición Almería, Spain Site recruitment: Recruiting
Hosp. Vithas Sevilla_Endocrino y Nutrición Castilleja de la Cuesta, Spain Site recruitment: Recruiting
Hospital Naval Ferrol Ferrol, Spain Site recruitment: Recruiting
Clínica Palacios Madrid Madrid, Spain Site recruitment: Recruiting
Clínica Gaias Santiago Santiago de Compostela, Spain Site recruitment: Recruiting
Clínica Nuevas Tecnologías en Diabetes y Endocrinología Seville, Spain Site recruitment: Recruiting
H. Infanta Luisa_Endocrino y Obesidad Seville, Spain Site recruitment: Recruiting
CTC GoCo Mölndal Mölndal, Sweden Site recruitment: Recruiting
Enheten för Kliniska Studier (EKS), Örebro Örebro, Sweden Site recruitment: Recruiting
CTC Stockholm Stockholm, Sweden Site recruitment: Recruiting
Start: 2024-11-01. Completion: 2027-02-03 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
BI 456906 (drug) — also listed as: survodutide
Semaglutide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Amsterdam UMC, location VUMC Amsterdam, Netherlands Site recruitment: Not reported
Start: 2026-06-23. Completion: 2027-03 (may be estimated). No results posted in this registry response.
Products and interventions (6)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
MWN109 1 (drug)
MWN109 2 (drug)
MWN109 3 (drug)
MWN109 4 (drug)
Placebo (drug)
Semaglutide Tablets (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Peking University People's Hospital Beijing, Beijing Municipality, China Site recruitment: Recruiting
Diabetes Mellitus, Type 2; Nicotine Addiction; Tobacco Dependence
Sponsor
Ottawa Heart Institute Research Corporation
Countries with listed sites
Canada
Registry dates and results
Start: 2026-02-13. Completion: 2027-07 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Semaglutide (drug)
Nicotine replacement (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Ottawa Heart Institute Ottawa, Ontario, Canada Site recruitment: Recruiting
Start: 2026-08-12. Completion: 2027-09-23 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
NNC0721-8060 (drug)
Semaglutide (drug)
Placebo (drug)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
ICON Early Phase Services, LLC Lenexa, Kansas, United States Site recruitment: Recruiting
ICON San Antonio, Texas, United States Site recruitment: Not yet recruiting
Start: 2026-03-26. Completion: 2027-12 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Enobosarm (drug)
Semaglutide (Wegovy) weekly injection (drug)
Where the study takes place — 13 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
DM Clinical Research - Phoenix Phoenix, Arizona, United States Site recruitment: Not reported
DM Clinical Research - MIA Doral, Florida, United States Site recruitment: Not reported
Universal Axon Clinical Research (Rovia - UACR) Doral, Florida, United States Site recruitment: Not reported
Paramo Health Miami, Florida, United States Site recruitment: Not reported
IMIC Research a Rovia Clinical Research Company Miami, Florida, United States Site recruitment: Not reported
Paramo Health Miami, Florida, United States Site recruitment: Not reported
Pennington Biomedical Research Center Baton Rouge, Louisiana, United States Site recruitment: Not reported
Centennial Medical Group (CMG) Columbia, Maryland, United States Site recruitment: Not reported
SKY Integrative Medical Center Ridgeland, Mississippi, United States Site recruitment: Not reported
ALSA Research New York, New York, United States Site recruitment: Not reported
Coastal Research Institute, LLC Fayetteville, North Carolina, United States Site recruitment: Not reported
DM Clinical - Dallas Irving, Texas, United States Site recruitment: Not reported
DM Clinical - Seattle Seattle, Washington, United States Site recruitment: Not reported
Fundación para la Investigación del Hospital Clínico de Valencia
Countries with listed sites
Spain
Registry dates and results
Start: 2025-05-26. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.
Products and interventions (10)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Metformin (drug)
Dulaglutide (drug)
Semaglutide 1.0 mg (drug)
Empagliflozin (BI 10773) (drug)
Canagliflozin (drug)
Dapagliflozin (drug)
pioglitazone (drug)
Sitagliptin (drug)
Vildagliptin (Galvus) (drug)
linagliptin (drug)
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Hospital Universitario Regional de Málaga Málaga, Spain Site recruitment: Not reported
Hospital Clínico Universitario de Valencia Valencia, Spain Site recruitment: Not reported
Hospital General Universitario de Valencia (HGUV) Valencia, Spain Site recruitment: Not reported
Greece · Hungary · Portugal · Serbia · Sweden · United States
Registry dates and results
Start: 2026-08-04. Completion: 2027-07-06 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Cagrilintide (drug)
Placebo cagrilintide (drug)
Placebo semaglutide (drug)
Where the study takes place — 36 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Hope Clin Res & Wellness Conyers, Georgia, United States Site recruitment: Recruiting
East West Med Res Inst Honolulu, Hawaii, United States Site recruitment: Recruiting
Walgreens - Store 11760 Oak Park, Illinois, United States Site recruitment: Not yet recruiting
Midwest Inst For Clin Res Indianapolis, Indiana, United States Site recruitment: Recruiting
The Alliance for Multispecialty Research LLC AMR Lexington, Kentucky, United States Site recruitment: Recruiting
PharmQuest Greensboro, North Carolina, United States Site recruitment: Recruiting
KDCILM, LLC & Accellacare US, Inc. Wilmington, North Carolina, United States Site recruitment: Recruiting
Coastal Carolina Res Ctr North Charleston, South Carolina, United States Site recruitment: Recruiting
Health Res of Hampton Roads Newport News, Virginia, United States Site recruitment: Recruiting
National Clin Res Inc. Richmond, Virginia, United States Site recruitment: Recruiting
Selma Medical Associates Winchester, Virginia, United States Site recruitment: Recruiting
General Hospital Of Athens Alexandra - Department of Endocrinology, Diabetes Center Athens, Greece Site recruitment: Recruiting
General Hospital Of Athens G Gennimatas - Department of Endocrinology Athens, Greece Site recruitment: Recruiting
General Hospital Venizeleio-Pananeio - Diabetic Clinic Irakleio, Greece Site recruitment: Recruiting
Athens Medical Center S.A. (Iatriko Peristeriou) - Diabetes, obesity and cardiometabolic diseases department Peristeri, Greece Site recruitment: Recruiting
Ippokratio General Hospital Of Thessaloniki - B' Internal Medicine clinic Thessaloniki, Greece Site recruitment: Recruiting
St. Luke's Hospital S.A. - Endocrinology Department and Obesity Clinic Thessaloniki, Greece Site recruitment: Recruiting
Stúdium Egészségház Kft. Kalocsa, Bács-Kiskun county, Hungary Site recruitment: Recruiting
Start: 2026-05-12. Completion: 2026-06-15 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Semaglutide (drug)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Novo Nordisk Investigational Site Seattle, Washington, United States Site recruitment: Not reported
Novo Nordisk Investigational Site London, United Kingdom Site recruitment: Not reported
Start: 2025-01-29. Completion: 2027-12-01 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Bariatric Surgery (procedure) — also listed as: Metabolic Surgery, Roux-en-Y Gastric Bypass (RYGB), Sleeve Gastrectomy (SG)
Semaglutide (drug) — also listed as: Ozempic, Wegovy
Tirzepatide (drug) — also listed as: Mounjaro, Zepbound
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The Cleveland Clinic Cleveland, Ohio, United States Site recruitment: Not reported
Pediatric Obesity; Metabolic and Bariatric Surgery; Semaglutide
Sponsor
Children's Hospital Los Angeles
Countries with listed sites
United States
Registry dates and results
Start: 2026-09-01. Completion: 2033-11-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Semaglutide 2.4 mg (drug) — also listed as: Wegovy
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Children's Hospital Los Angeles Los Angeles, California, United States Site recruitment: Recruiting
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.